Literature DB >> 20979016

Clinical studies with traditional Chinese medicine in the past decade and future research and development.

Miao Jiang1, Jing Yang, Chi Zhang, Baoyan Liu, Kelvin Chan, Hongxin Cao, Aiping Lu.   

Abstract

Traditional Chinese medicine (TCM) is currently considered a complementary or alternative medical system in most Western countries and has been increasingly accepted worldwide. More and more clinical trials on TCM have been conducted internationally, and scientists worldwide are becoming increasingly interested in the evaluation of clinical efficacy of TCM based on clinical trials. This paper reviews the situation of clinical trials on TCM in the past decade, including systematic reviews about clinical trials either focusing on the treatment of disease with TCM approaches or focusing on one herbal product, conduction of clinical trials on TCM either with randomization and controlled methods or general observation. Some general issues on the conduct of clinical trials on TCM, such as randomization, control, quality of life (QOL), patient reported outcomes (PROs) and biomarkers, quality control, safety evaluation and case studies, are discussed, and accordingly some suggestions are proposed. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20979016     DOI: 10.1055/s-0030-1250456

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  27 in total

1.  Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.

Authors:  Yu Qi; Xinhui Cheng; Huiting Jing; Tingxu Yan; Feng Xiao; Bo Wu; Kaishun Bi; Ying Jia
Journal:  Metab Brain Dis       Date:  2019-08-17       Impact factor: 3.584

2.  Identification of cortex herbs using the DNA barcode nrITS2.

Authors:  Zhiying Sun; Shilin Chen
Journal:  J Nat Med       Date:  2012-07-17       Impact factor: 2.343

Review 3.  Nonallergen-specific treatments for food allergy.

Authors:  Jay A Lieberman; Julie Wang
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-06

4.  Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients.

Authors:  Yi Li; Han-xu Xi; Sha Zhu; Na Yu; Jing Wang; Yan Li; Guo-pei Yu; Xie-min Ma; Jun Zhang; Lue-ping Zhao
Journal:  Chin J Integr Med       Date:  2014-08-05       Impact factor: 1.978

5.  What can comparative effectiveness research, propensity score and registry study bring to Chinese medicine?

Authors:  Xing Liao; Yan-ming Xie
Journal:  Chin J Integr Med       Date:  2014-03-07       Impact factor: 1.978

Review 6.  Barriers and countermeasures in developing traditional Chinese medicine in Europe.

Authors:  Yunfang Liu; Zhiping Yang; Jing Cheng; Daiming Fan
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592

7.  Barley grass extract causes apoptosis of cancer cells by increasing intracellular reactive oxygen species production.

Authors:  Sang Mi Woo; Sang-Chul Kwon; Seong Gyu Ko; Sung-Gook Cho
Journal:  Biomed Rep       Date:  2017-05-03

8.  Traditional chinese medicine zheng in the era of evidence-based medicine: a literature analysis.

Authors:  Miao Jiang; Chi Zhang; Guang Zheng; Hongtao Guo; Li Li; Jing Yang; Cheng Lu; Wei Jia; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-06       Impact factor: 2.629

9.  Evaluation of chinese-herbal-medicine-induced herb-drug interactions: focusing on organic anion transporter 1.

Authors:  Chang-Ching Lin; Hsien-Yuan Fan; Chien-Wen Kuo; Li-Heng Pao
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

Review 10.  Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in chinese.

Authors:  Xun Li; Guoyan Yang; Xinxue Li; Yan Zhang; Jingli Yang; Jiu Chang; Xiaoxuan Sun; Xiaoyun Zhou; Yu Guo; Yue Xu; Jianping Liu; Alan Bensoussan
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.